Clot Burden Score on Admission T2*-MRI Predicts Recanalization in Acute Stroke
暂无分享,去创建一个
Catherine Oppenheim | Jean-Claude Baron | Emmanuel Touzé | David Calvet | Pauline Roca | Charles Mellerio | Olivier Naggara | Jean-François Meder | J. Baron | D. Calvet | C. Oppenheim | O. Naggara | J. Meder | E. Touzé | J. Mas | C. Mellerio | G. Turc | P. Roca | Jean-Louis Mas | Guillaume Turc | L. Legrand | Marc-Antoine Labeyrie | M. Labeyrie | Laurence Legrand
[1] Zsolt Garami,et al. Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke , 2007, Stroke.
[2] S. Warach,et al. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. , 2005, AJNR. American journal of neuroradiology.
[3] Günther Deuschl,et al. The Importance of Size: Successful Recanalization by Intravenous Thrombolysis in Acute Anterior Stroke Depends on Thrombus Length , 2011, Stroke.
[4] N. Petitti. The hyperdense middle cerebral artery sign. , 1998, Radiology.
[5] G. Schroth,et al. Comparison of Intraarterial and Intravenous Thrombolysis for Ischemic Stroke With Hyperdense Middle Cerebral Artery Sign , 2008, Stroke.
[6] H. Chabriat,et al. Intra-Arterial Thrombus Visualized on T2* Gradient Echo Imaging in Acute Ischemic Stroke , 2005, Cerebrovascular Diseases.
[7] A. Demchuk,et al. Intracranial Thrombus Extent Predicts Clinical Outcome, Final Infarct Size and Hemorrhagic Transformation in Ischemic Stroke: The Clot Burden Score , 2008, International journal of stroke : official journal of the International Stroke Society.
[8] A. Demchuk,et al. Role of Recanalization in Acute Stroke Outcome: Rationale for a CT Angiogram-Based “Benefit of Recanalization” Model , 2008, American Journal of Neuroradiology.
[9] J. Grotta,et al. Thrombus Burden Is Associated With Clinical Outcome After Intra-Arterial Therapy for Acute Ischemic Stroke , 2008, Stroke.
[10] Manabu Inoue,et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study , 2012, The Lancet Neurology.
[11] Takashi Inoue,et al. Clinical and MRI Predictors of No Early Recanalization Within 1 Hour After Tissue-Type Plasminogen Activator Administration , 2011, Stroke.
[12] J. Broderick,et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. , 1996, AJNR. American journal of neuroradiology.
[13] T. Kinoshita,et al. Changes in susceptibility signs on serial T2*-weighted single-shot echo-planar gradient-echo images in acute embolic infarction: comparison with recanalization status on 3D time-of-flight magnetic resonance angiography , 2012, Neuroradiology.
[14] C. Oppenheim,et al. Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis , 2011, Neurology.
[15] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.
[16] À. Rovira,et al. Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. , 2004, Radiology.
[17] A. Demchuk,et al. CT Angiography Clot Burden Score and Collateral Score: Correlation with Clinical and Radiologic Outcomes in Acute Middle Cerebral Artery Infarct , 2009, American Journal of Neuroradiology.
[18] W. Hacke,et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.
[19] N. Salamon,et al. CT and MRI Early Vessel Signs Reflect Clot Composition in Acute Stroke , 2011, Stroke.
[20] K. Kimura,et al. M1 Susceptibility Vessel Sign on T2* as a Strong Predictor for No Early Recanalization After IV-t-PA in Acute Ischemic Stroke , 2009, Stroke.
[21] Catherine Oppenheim,et al. Diffusion Lesion Reversal After Thrombolysis: A MR Correlate of Early Neurological Improvement , 2012, Stroke.
[22] I. Elovaara,et al. The clot burden score, the Boston Acute Stroke Imaging Scale, the cerebral blood volume ASPECTS, and two novel imaging parameters in the prediction of clinical outcome of ischemic stroke patients receiving intravenous thrombolytic therapy , 2012, Neuroradiology.
[23] H. Urbach,et al. Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. , 2000, Radiology.
[24] S. Kwon,et al. Significance of Susceptibility Vessel Sign on T2*-Weighted Gradient Echo Imaging for Identification of Stroke Subtypes , 2005, Stroke.
[25] Sang Joon Kim,et al. Progression of middle cerebral artery susceptibility sign on T2*-weighted images: its effect on recanalization and clinical outcome after thrombolysis. , 2006, AJR. American journal of roentgenology.
[26] K. Kimura,et al. M 1 Susceptibility Vessel Sign on T 2 * as a Strong Predictor for No Early Recanalization After IV-tPA in Acute Ischemic Stroke , 2009 .
[27] Jeffrey L Saver,et al. The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis , 2007, Stroke.
[28] H. Urbach,et al. Middle Cerebral Artery (MCA) Susceptibility Sign at Susceptibility-based Perfusion MR Imaging: Clinical Importance and Comparison with Hyperdense MCA Sign at CT 1 , 2000 .
[29] P. Nederkoorn,et al. Proximal and distal hyperattenuating middle cerebral artery signs at CT: different prognostic implications. , 2002, Radiology.